ACADIA PHARMACEUTICALS INC (ACAD) › Total LiabilitiesACADIA PHARMACEUTICALS INC (ACAD) — Total LiabilitiesAnnual figures by fiscal year, from SEC filings.2010: $8.71M2011: $8.75M2012: $5.95M2013: $6.99M2014: $15.97M2015: $22.13M2016: $42.74M2017: $49.22M2018: $61.12M2019: $84.05M2020: $155.61M2021: $159.23M2022: $187.40M2023: $317.20M2024: $454.96M2025: $336.81M$336.81M2010Total Liabilities (USD)2025Fiscal YearTotal LiabilitiesChange YoY2025$336.81M-26.0%2024$454.96M+43.4%2023$317.20M+69.3%2022$187.40M+17.7%2021$159.23M+2.3%2020$155.61M+85.1%2019$84.05M+37.5%2018$61.12M+24.2%2017$49.22M+15.2%2016$42.74M+93.1%2015$22.13M+38.6%2014$15.97M+128.6%2013$6.99M+17.5%2012$5.95M-32.0%2011$8.75M+0.5%2010$8.71M—Other metrics: RevenueCost of RevenueGross ProfitOperating IncomeNet IncomeEPS (Diluted)Total AssetsShareholders' EquityCash & EquivalentsOperating Cash FlowCapital ExpendituresShares OutstandingDividends Per Share